|
1
|
Zuberbier T, Aberer W, Asero R,
Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF,
Giménez-Arnau A, Godse K, et al: European Academy of Allergy and
Clinical Immunology; Global Allergy and Asthma European Network;
European Dermatology Forum; World Allergy Organization: The
EAACI/GA(2) LEN/EDF/WAO Guideline for the definition,
classification, diagnosis, and management of urticaria: The 2013
revision and update. Allergy. 69:868–887. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bernstein JA, Lang DM, Khan DA, Craig T,
Dreyfus D, Hsieh F, Sheikh J, Weldon D, Zuraw B, Bernstein DI, et
al: The diagnosis and management of acute and chronic urticaria:
2014 update. J Allergy Clin Immunol. 133:1270–1277. 2014.
|
|
3
|
Lapi F, Cassano N, Pegoraro V, Cataldo N,
Heiman F, Cricelli I, Levi M, Colombo D, Zagni E, Cricelli C, et
al: Epidemiology of chronic spontaneous urticaria: Results from a
nationwide, population-based study in Italy. Br J Dermatol.
174:996–1004. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maurer M, Weller K, Bindslev-Jensen C,
Giménez-Arnau A, Bousquet PJ, Bousquet J, Canonica GW, Church MK,
Godse KV, Grattan CE, et al: Unmet clinical needs in chronic
spontaneous urticaria. A GA2LEN task force report.
Allergy. 66:317–330. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhong H, Song Z, Chen W, Li H, He L, Gao
T, Fang H, Guo Z, Xv J, Yu B, et al: Chronic urticaria in Chinese
population: A hospital-based multicenter epidemiological study.
Allergy. 69:359–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rabelo-Filardi R, Daltro-Oliveira R and
Campos RA: Parameters associated with chronic spontaneous urticaria
duration and severity: A systematic review. Int Arch Allergy
Immunol. 161:197–204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Asero R: D-dimer: A biomarker for
antihistamine-resistant chronic urticaria. J Allergy Clin Immunol.
132:983–986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Altrichter S, Boodstein N and Maurer M:
Matrix metalloproteinase-9: A novel biomarker for monitoring
disease activity in patients with chronic urticaria patients?
Allergy. 64:652–656. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grzanka A, Machura E, Misiolek M, Polaniak
R, Kasperski J and Kasperska-Zajac A: Systemic inflammatory
response and calcification markers in patients with long lasting
moderate-severe chronic spontaneous urticaria. Eur J Dermatol.
25:26–28. 2015.PubMed/NCBI
|
|
10
|
Kolkhir P, André F, Church MK, Maurer M
and Metz M: Potential blood biomarkers in chronic spontaneous
urticaria. Clin Exp Allergy. 47:19–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takahagi S, Mihara S, Iwamoto K, Morioke
S, Okabe T, Kameyoshi Y and Hide M: Coagulation/fibrinolysis and
inflammation markers are associated with disease activity in
patients with chronic urticaria. Allergy. 65:649–656. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim JH, Lee HY, Ban GY, Shin YS, Park HS
and Ye YM: Serum clusterin as a prognostic marker of chronic
spontaneous urticaria. Medicine (Baltimore). 95:e36882016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujii K, Usuki A, Kan-No Y and Ohgou N:
Elevation of circulating thrombin-antithrombin III complex and
fibrin degradation products in urticaria: A laboratory finding
unrelated to intravascular coagulopathy. J Dermatol. 35:308–310.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kasperska-Zajac A, Grzanka A, Machura E,
Misiolek M, Mazur B and Jochem J: Increased serum complement C3 and
C4 concentrations and their relation to severity of chronic
spontaneous urticaria and CRP concentration. J Inflamm (Lond).
10:222013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lundberg KC, Fritz Y, Johnston A, Foster
AM, Baliwag J, Gudjonsson JE, Schlatzer D, Gokulrangan G, McCormick
TS, Chance MR, et al: Proteomics of skin proteins in psoriasis:
From discovery and verification in a mouse model to confirmation in
humans. Mol Cell Proteomics. 14:109–119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shao Q, Byrum SD, Moreland LE, Mackintosh
SG, Kannan A, Lin Z, Morgan M, Stack BC Jr, Cornelius LA, Tackett
AJ, et al: A proteomic study of human merkel cell carcinoma. J
Proteomics Bioinform. 6:275–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meral O and Uysal H: Comparative proteomic
analysis of fibrosarcoma and skin fibroblast cell lines. Tumour
Biol. 36:561–567. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Erler A, Hawranek T, Krückemeier L, Asam
C, Egger M, Ferreira F and Briza P: Proteomic profiling of birch
(Betula verrucosa) pollen extracts from different origins.
Proteomics. 11:1486–1498. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Broccardo CJ, Mahaffey S, Schwarz J, Wruck
L, David G, Schlievert PM, Reisdorph NA and Leung DY: Comparative
proteomic profiling of patients with atopic dermatitis based on
history of eczema herpeticum infection and Staphylococcus aureus
colonization. J Allergy Clin Immunol. 127:186–193, e1-193.e11.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holm T, Rutishauser D, Kai-Larsen Y,
Lyutvinskiy Y, Stenius F, Zubarev RA, Agerberth B, Alm J and
Scheynius A: Protein biomarkers in vernix with potential to predict
the development of atopic eczema in early childhood. Allergy.
69:104–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
O'Neil SE, Sitkauskiene B, Babusyte A,
Krisiukeniene A, Stravinskaite-Bieksiene K, Sakalauskas R, Sihlbom
C, Ekerljung L, Carlsohn E and Lötvall J: Network analysis of
quantitative proteomics on asthmatic bronchi: Effects of inhaled
glucocorticoid treatment. Respir Res. 12:1242011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okamoto T, Miyazaki Y, Shirahama R,
Tamaoka M and Inase N: Proteome analysis of bronchoalveolar lavage
fluid in chronic hypersensitivity pneumonitis. Allergol Int.
61:83–92. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kasperska-Zajac A: Acute-phase response in
chronic urticaria. J Eur Acad Dermatol Venereol. 26:665–672. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kasperska-Zając A, Grzanka A, Czecior E,
Misiolek M, Rogala B and Machura E: Acute phase inflammatory
markers in patients with non-steroidal anti-inflammatory drugs
(NSAIDs)-induced acute urticaria/angioedema and after aspirin
challenge. J Eur Acad Dermatol Venereol. 27:1048–1052. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wedi B, Raap U, Wieczorek D and Kapp A:
Urticaria and infections. Allergy Asthma Clin Immunol. 5:102009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sabroe RA, Grattan CE, Francis DM, Barr
RM, Black Kobza A and Greaves MW: The autologous serum skin test: A
screening test for autoantibodies in chronic idiopathic urticaria.
Br J Dermatol. 140:446–452. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dreyfus DH: Autoimmune disease: A role for
new anti-viral therapies? Autoimmun Rev. 11:88–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kasperska-Zajac A, Brzoza Z and Rogala B:
Sex hormones and urticaria. J Dermatol Sci. 52:79–86. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kasperska-Zajac A, Brzoza Z and Rogala B:
Serum concentration of dehydroepiandrosterone sulphate in female
patients with chronic idiopathic urticaria. J Dermatol Sci.
41:80–81. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takeda T, Sakurai Y, Takahagi S, Kato J,
Yoshida K, Yoshioka A, Hide M and Shima M: Increase of coagulation
potential in chronic spontaneous urticaria. Allergy. 66:428–433.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jansen PM, Boermeester MA, Fischer E, de
Jong IW, van der Poll T, Moldawer LL, Hack CE and Lowry SF:
Contribution of interleukin-1 to activation of coagulation and
fibrinolysis, neutrophil degranulation, and the release of
secretory-type phospholipase A2 in sepsis: Studies in nonhuman
primates after interleukin-1 α administration and during lethal
bacteremia. Blood. 86:1027–1034. 1995.PubMed/NCBI
|
|
32
|
Sodin-Šemrl S, Žigon P, Čučnik S, Kveder
T, Blinc A, Tomšič M and Rozman B: Serum amyloid A in autoimmune
thrombosis. Autoimmun Rev. 6:21–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Migita K, Izumi Y, Jiuchi Y, Kozuru H,
Kawahara C, Izumi M, Sakai T, Nakamura M, Motokawa S, Nakamura T,
et al: Effects of Janus kinase inhibitor tofacitinib on circulating
serum amyloid A and interleukin-6 during treatment for rheumatoid
arthritis. Clin Exp Immunol. 175:208–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dogan S and Atakan N: Is serum amyloid A
protein a better indicator of inflammation in severe psoriasis? Br
J Dermatol. 163:895–896. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Niemi K, Baumann MH, Kovanen PT and Eklund
KK: Serum amyloid A (SAA) activates human mast cells which leads
into degradation of SAA and generation of an amyloidogenic SAA
fragment. Biochim Biophys Acta. 1762:424–430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Niemi K, Teirilä L, Lappalainen J,
Rajamäki K, Baumann MH, Öörni K, Wolff H, Kovanen PT, Matikainen S
and Eklund KK: Serum amyloid A activates the NLRP3 inflammasome via
P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol.
186:6119–6128. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Krause K, Metz M, Makris M, Zuberbier T
and Maurer M: The role of interleukin-1 in allergy-related
disorders. Curr Opin Allergy Clin Immunol. 12:477–484. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Büyüköztürk S, Gelincik AA, Genç S, Koçak
H, Oneriyidogan Y, Erden S, Dal M and Colakoglu B: Acute phase
reactants in allergic airway disease. Tohoku J Exp Med.
204:209–213. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lorenzo GD, Mansueto P, Melluso M, Candore
G, Cigna D, Pellitteri ME, Salvo AD and Caruso C: Blood eosinophils
and serum eosinophil cationic protein in patients with acute and
chronic urticaria. Mediators Inflamm. 5:113–115. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pazdrak K, Young TW, Straub C, Stafford S
and Kurosky A: Priming of eosinophils by GM-CSF is mediated by
protein kinase C betaII-phosphorylated L-plastin. J Immunol.
186:6485–6496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zheng W, Wang J, Zhu W, Xu C and He S:
Upregulated expression of substance P in basophils of the patients
with chronic spontaneous urticaria: Induction of histamine release
and basophil accumulation by substance P. Cell Biol Toxicol.
32:217–228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gunning PW, Hardeman EC, Lappalainen P and
Mulvihill DP: Tropomyosin - master regulator of actin filament
function in the cytoskeleton. J Cell Sci. 128:2965–2974. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
von der Ecken J, Müller M, Lehman W,
Manstein DJ, Penczek PA and Raunser S: Structure of the
F-actin-tropomyosin complex. Nature. 519:114–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Manstein DJ and Mulvihill DP:
Tropomyosin-mediated regulation of cytoplasmic myosins. Traffic.
17:872–877. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ono S and Ono K: Tropomyosin inhibits
ADF/cofilin-dependent actin filament dynamics. J Cell Biol.
156:1065–1076. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zanoni I and Granucci F: Role of CD14 in
host protection against infections and in metabolism regulation.
Front Cell Infect Microbiol. 3:322013. View Article : Google Scholar : PubMed/NCBI
|
